InvestorsHub Logo
Post# of 84359
Next 10
Followers 12
Posts 409
Boards Moderated 0
Alias Born 06/19/2018

Re: None

Sunday, 11/11/2018 6:52:23 PM

Sunday, November 11, 2018 6:52:23 PM

Post# of 84359
CELZ has had almost no attention until November/December of 2017 where they are now a Commercial stage company after many years of research and development towards their patents/procedures. Even earlier posts were very limited until around November of 2017.

They have been working on the science of it all for many years, at which point in late 2017 with CaverStem doing so well it is hitting the market and soon with other patents to follow.

according to data I have found in my research they have been in the works since well before 2011 and to me is very great news! They are not a scam in any way as they would not have worked for over 7+ years just to scam people. They have shown that they are a science/results and proof first company proceeding to commercialization when they are sure their patents/procedures are ready, safe and effective and are very picky on their doctors who will offer their patents/procedures as to prevent tarnishing their name/patents/procedures and protecting patients. (This is of course in My own Opinion)

It would seem that Creative Medical Technology Holdings, Inc. had changed JLLM to CELZ in May of 2016 in preparation for commercialization, “a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments. Since 2011 Creative Medical Technology Holdings, Inc. (CMTH) and our affiliate company Creative Medical Health, Inc. have focused on regenerative medical solutions for unmet Urological and Neurological needs. Through our own research and collaborations with leading academic institutions, CMT has acquired a groundbreaking stem cell (Amniostem), developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction, launched a 40-patient trial for ED at UCLA and are breaking new ground for treating stroke using our newly acquired amniotic fluid-based stem cell. Our team consists of leading international researchers in regenerative medicine. Our “science-first” approach to treatments ensures that all of our treatments are proven to be both safe and effective. “
http://www.creativemedicaltechnology.com/about-us/company/
and now are a commercial stage company.

Doctors and scientific advisory board
Thomas Ichim PhD
http://www.creativemedicaltechnology.com/about-us/board-of-directors/
Amit Patel MS MD
http://www.creativemedicaltechnology.com/about-us/board-of-directors/
Alexander Gershman, M.D.
http://www.caverstem.com/find-a-doctor-2/
Eric Duckers MD PhD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Timothy Henry MD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Warren Sherman MD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Masato Mitsuhashi MD PhD
http://www.creativemedicaltechnology.com/about-us/scientific-advisory-board/
Dr. Santosh Kesari
"Dr. Ichim represents a true visionary in the area of cellular therapy, being one of the few people that effectively combines deep knowledge of basic science, regulatory affairs, and clinical translation. I plan to leverage our existing strengths at the Pacific Neurosciences Institute and at St John Providence to accelerate neurological uses of the Company's AmnioStemTM stem cell, particularly in the indication of post-stroke recovery," said Dr. Santosh Kesari, MD, PhD, FANA, FAAN, Scientific Advisory Board Member of CELZ. Dr. Kesari is Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, as well as Director of Neuro-oncology, Providence Saint John's Health Center and leads the Pacific Neuroscience Research Center at Pacific Neuroscience Institute.
https://www.prnewswire.com/news-releases/creative-medical-technology-holdings-appoints-internationally-renowned-stem-cell-pioneer-as-chief-scientific-officer-300419991.html

https://www.pacificneuroscienceinstitute.org/people/kesari/

Jacob Rajfer MD - doctor who was responsible for the original journals that led to the creation of Viagra/Cialis, lead the Caverstem trial that concluded in August 2018.

Websites
http://www.creativemedicaltechnology.com/
http://www.caverstem.com/
http://www.caverstem-oc.com/
http://www.caverstem-nv.com/
http://www.caverstem-nm.com/
http://www.caverstem-florida.com/
http://www.caverstem-sandiego.com/
http://www.caverstem-sanfrancisco.com/
http://www.caverstem-losangeles.com/
http://www.caverstem-phoenix.com/
http://www.caverstem.com/find-a-doctor-2/

Many more that show via ‘Who Is’ lookup are registered to the same person/place/company that are not yet active.

All posts my opinions, NOT INVESTMENT ADVICE. Do your own due diligence

-- Narrow is the way and few are those who find it. --

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.